Stereotactic ablative radiotherapy tops for inoperable early NSCLC

Australian and New Zealand research confirms what clinicians suspected

Compared with standard radiotherapy, stereotactic ablative body radiotherapy (SABR) provides better local control and improved survival in patients with inoperable non-small-cell lung cancer (NSCLC), according to results of the CHISEL study.